1 min read

GP Letrozole (Femara)

GP Letrozole (Femara)



Manufacturer: Geneza Pharmaceuticals
Substance: Letrozole
Pack: 20 tabs (2.5 mg/tab)

GP Letrozole by Geneza Pharmaceuticals contains 2.5mg of the substance Letrozole. This steroid is considering an extremely potent anti-estrogen and is known in bodybuilding as Letro.

For the beginning Letro was used to treat breast cancer in women. It was also used by bodybuilders who were sensitive to estrogen related side effects, or in heavy bulking cycles. In bodybuilding this steroid is very popular too, because it has been shown to reduce estrogen levels by 98% or more. Those mean as less estrogen in the body means less chance of certain side effects such as water-retention and acne.

Another thing that make it famous between competitive bodybuilder is: no other drug will produce a dry and tight look like Letro will. It also may reduce/eliminate/reverse existing gynocomastia.

Letrozole can be used to raise LH and FSH, hormones which signal testes to produce more testosterone; this mechanism will raise testosterone levels. Letro can be used for post-cycle-therapy to raise test levels.
While too much estrogen can be harmful and bring about unwanted side effects, it’s important that bodybuilders don’t totally eliminate estrogen all together, for its presence is vital for optimum muscle growth and also for keeping a healthy sex drive.

Some bodybuilders compare GP Letrozole with Anastrozole. But we can tell for sure that Letro  is about 3 times stronger than Anastrozole, and is recommended to be used by those who have found that Anastrozole wasn’t strong enough to keep estrogenic related side effects under control.

An effective dose of Letrozole ( Femara) is 2.5-5.0mg/day. Anything more than this will generally reduce estrogen too much in the body and kill sex drive.

You can BUY this product at discount prices  from DaddyRoids.Net because  they proved good themselves on market and have good reputation.

Written by: Golden Muscles
© May  2010
www.goldenmuscles.com All rights reserved. Reprint article with link only

Leave a Reply

Latest from Blog